Results of coronary angioplasty in diabetic and non diabetic patients. A one year follow-up study;Estudio comparativo de la angioplastia coronaria en pacientes con diabetes. Resultados clínicos y angiográficos inmediatos y evolución clínica en el primer año

Revista Medica de Chile

Volumn 129, Issue 8, 2001, Pages 861-870

  Dussaillant N, Gastón ^a,b   Pacheco C, Claudio ^a   Ramírez N, Alfredo ^a   Ugalde P, Héctor ^a   Antibilo G, Soledad ^a   Silva J, Ana María ^a   Farías C, Eric ^a   Oyonarte G, Miguel ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Angioplasty, balloon; Angioplasty, transluminal, percutaneous coronary; Coronary thrombosis; Diabetes mellitus; Diabetic angiopathies

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; RESTENOSIS; RISK FACTOR; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; CORONARY RESTENOSIS; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0347033945     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. KANNEL WB, MCGEE DL. Diabetes and Cardiovascular Disease: The Framingham Study. JAMA 1979; 241: 2035-8.
2. STAMLER J, VACCARO O, NEATON JD, WENTWORTH D. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16: 434-44.
3. UUSITUPA MIJ, NISKANEN LK, SIITONEN O, VOUTILAINEN E, PYORALA K. 5 years incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and non diabetic subjects. Circulation 1990; 82: 27-36.
4. STEIN B, WEINTRAUB WS, GEBHART SSP, COHENBERNSTEIN CL, GROSSWALD R, LIBERMAN HA ET AL. Influence of Diabetes Mellitus on Early and Late Outcome After Percutaneous Transluminal Coronary Angioplasty. Circulation 1995; 91: 979-89.
5. KIP KE, FAXON DP, DETRE KM, YEH W, KELSEY SF, CURRIER JW. Coronary Angioplasty in Diabetic Patients: The National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996; 94: 1818-25.
6. ABIZAID A, KORNOWSKI R, MINTZ GS, HONG MK, ABIZAID AS, MEHRAN R ET AL. The Influence of Diabetes Mellitus on Acute and Late Clinical Outcomes Following Coronary Stent Implantation. J Am Coll Cardiol 1998; 32: 584-9.
7. VAN DOMBURG RT, FOLEY DP, DE JAEGERE PPT, DE FEYTER P, VAN DEN BRAND M, VAN DER GIESSEN W ET AL. Long-Term Outcome After Coronary Stent Implantation: A 10 Years Single Center Experience of 1000 Patients. Heart 1999; 82 (Suppl II): II27-II34.
8. KILLIP T, KIMBALL JT. Treatment of myocardial infarction in a coronary care unit. A two years experience with 250 patients. Am J Cardiol 1967; 20: 457-64.
9. DUSSAILLANT G, AYALA F, RAMÍREZ A, UGALDE H, SILVA AM, FARÍAS E, OYONARTE M. Implante de prótesis endovasculares (stents) en el tratamiento de la cardiopatía coronaria: Resultados angiográficos, clínicos inmediatos y tardíos. Rev Méd Chile 1998; 126: 1195-205.
10. THE TIMI STUDY GROUP. The thrombolisis in myocardial infarction (TIMI) trial. N Engl J Med 1985; 31: 932-6.
11. FISCHMAN DL, LEON MB, BAIM DS, SCHATZ RA, SAVAGE MP, PENN I ET AL, FOR THE STENT RESTENOSIS STUDY GROUP. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
12. SERRUYS PW, DE JAEGERE P, KIEMENEIJ F, MACAYA C, RUTSCH W, HEYNDRICKX G ET AL FOR THE BENESTENT STUDY GROUP. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.
13. SERRUYS PW, EMANUELSSON H, VAN DER GIESEN W, LUNN A, KIEMENEIJ F, MACAYA C ET AL ON BEHALF OF THE BENESTENT II STUDY GROUP. Heparin-coated Palmaz-Schatz stent in human coronary arteries. Early outcome of the Benestent II Pilot Study. Circulation 1996; 93: 412-22.
14. KORNOWSKI R, MINTZ GS, LANSKY AJ, HONG MK, KENT KM, PICHARD AD. Paradoxic Decreases in Atherosclerotic Plaque Mass in Insulin-Treated Diabetic Patients. Am J Cardiol 1998; 81: 1298-304.
15. TOPOL EJ, MARK DB, LINCOFF AM, COHEN E, BURTON J, KLEIMAN N, TALLEY D, SAPP S, BOOTH J, CABOT CF, ANDERSON KM, CALIFF RM. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1999; 354: 2019-24.
16. LEON MB, BAIM DS, POPMA JJ, GORDON PC, CUTLIP DE, HO KKL ET AL. A Clinical Trial Comparing Three Antithrombotic-Drug Regimens After Coronary-Artery Stenting. N Engl J Med 1998; 339: 1665-71.
17. MARSO SP, LINCOFF AM, ELLIS SG, BHATT DL, TANGUAY JF, KLEIMAN NS ET AL. Optimizing the Percutaneous Interventional Outcomes for Patients With Diabetes Mellitus. Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) Diabetic Substudy. Circulation 1999; 100: 2477-84.
18. BHATT DL, MARSO SP, LINCOFF AM, WOLSKI KE, ELLIS SG, TOPOL EJ. Abciximab Reduces Mortality in Diabetics Following Percutaneous Coronary Intervention. J Am Coll Cardiol 2000; 35: 922-8.
19. ROZENMAN Y, SAPOZNIKOV D, MOSSERI M, GILON D, LOTAN C, NASSAR H ET AL. Long-Term Angiographic Follow-Up of Coronary-Balloon Angioplasty in Patients With Diabetes Mellitus, a Clue to the Explanation of the Results of the BARI Study. J Am Coll Cardiol 1997; 30: 1420-5.
20. LAU KW, DING ZP, JOHAN A AND LIM YL. Midterm Angiographic Outcome of Single-Vessel Intracoronary Stent Placement in Diabetic Versus Nondiabetic Patients: A Matched Comparative Study. Am Heart J 1998; 136: 150-5.
21. SCHOFER J, SCHLÜTER M, RAU T, HAMMER F, HAAG N AND MATHEY DG. Influence of Treatment Modality on Angiographic Outcome After Coronary Stenting in Diabetic Patients: A Controlled Study. J Am Coll Cardiol 2000; 35: 1554-9.
22. BAUMGARTNER-PARZER SM, TSCHOEPE D. Role of Adhesion Molecules in Diabetes Mellitus. Horm Metab Res 1997; 29: 613.
23. TSCHOEPE D, RAUCH U, SCHWIPPERT B. Platelet-Leukocyte Cross-Talk in Diabetes Mellitus. Harm Metab Res 1997; 29: 631-5.
24. COLEMAN KR, BRADEN GA, WILLINGHAM MC, SANE DC. Vitaxin, a humanized Monoclonal Antibody to the Vitronectin Receptor, Reduces Neointimal Hyperplasia and Total Vessel Area After Balloon Injury in Hypercholesterolemic Rabbits. Circ Res 1999; 84: 1268-76.
25. KNOBLER H, SAVION N, SHENKMAN B, KOTEV-EMETH S, VARON D. Sher-Induced Platelet Adhesion and Aggregation on Subendothelium are Increased in Diabetic Patients. Thromb Res 1998; 90: 181-90.
26. COLOMBO A, HALL P, NAKAMURA S, ALMMAGOR Y, MAIELLO L, MARTINI G ET AL. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-88.
27. SCHOMIG A, NEUMANN FJ, KASTRATI A, SCHUHLEN H, BLASINI R, HADAMITZHY M ET AL. A randomized comparison of antiplatelet and anticoagulant therapy after placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-9.
28. DUSSAILLANT GR, MINTZ GS, PICHARD AD, KENT KM, SATLER LF, POPMA JJ ET AL. Small Stent Size and Intimal Hyperplasia Contribute to Restenosis: A Volumetric Intravascular Ultrasound Analysis. J Am Coll Cardiol 1995; 26: 720-4.
29. HOFFMANN R, MINTZ GS, DUSSAILLANT GR, POPMA JJ, PICHARD AD, SATLER AD ET AL. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996; 94: 1247-54.
30. KORNOWSKI R, MINTZ GS, KENT KM, PICHARD AD, SATLER LF, BUCHER TA ET AL. Increased Restenosis in Diabetes Mellitus After Coronary Interventions Is Due to Exaggerated Intimai Hyperplasia: A Serial Intravascular Ultrasound Study. Circulation 1997; 95: 1366-9.